Turner syndrome and metabolic derangements: Another example of fetal programming

Ogden, 2006, Prevalence of overweight and obesity in the United States, 1999–2004, JAMA, 295, 1549, 10.1001/jama.295.13.1549 Reilly, 2003, Health consequences of obesity, Arch Dis Child, 88, 748, 10.1136/adc.88.9.748 McMillen, 2005, Developmental origins of the metabolic syndrome: prediction, plasticity and programming, Physiol Rev, 85, 571, 10.1152/physrev.00053.2003 Ismail-Beigi, 2006, Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult, Am J Physiol Endocrinol Metab, 291, 439, 10.1152/ajpendo.00105.2006 Druet, 2008, Early childhood predictors of adult body composition, Best Pract Res Clin Endocrinol Metab, 22, 489, 10.1016/j.beem.2008.02.002 Ross, 2008, Adult sequelae of intrauterine growth restriction, Semin Perinatol, 32, 213, 10.1053/j.semperi.2007.11.005 Simmons, 2008, Perinatal programming of obesity, Semin Perinatol, 32, 371, 10.1053/j.semperi.2008.08.004 Srinivasan, 2008, Metabolic programming in the immediate postnatal period, Trends Endocrinol Metab, 19, 146, 10.1016/j.tem.2007.12.001 Patel, 2009, Metabolic programming: role of nutrition in the immediate postnatal life, J Inherit Metab Dis, 32, 218, 10.1007/s10545-008-1033-4 Tamashiro, 2010, Perinatal environment and its influences on metabolic programming of offspring, Physiol Behav, 100, 560, 10.1016/j.physbeh.2010.04.008 Lucas, 1991, Programming by early nutrition in man, Ciba Found Symp, 156, 38 Barker, 1995, The fetal and infant origins of disease, Eur J Clin Invest, 25, 457, 10.1111/j.1365-2362.1995.tb01730.x Blackett, 2000, Body mass index (BMI) in Turner syndrome before and during growth hormone (GH) therapy, Int J Obes Relat Metab Disord, 24, 232, 10.1038/sj.ijo.0801119 Van, 2006, Monosomy for the X-chromosome is associated with an atherogenic lipid profile, J Clin Endocrinol Metab, 91, 2867, 10.1210/jc.2006-0503 Mazzanti, 2005, Turner syndrome, insulin sensitivity and growth hormone treatment, Horm Res, 64, 51, 10.1159/000089318 Shoemaker, 2008, United Kingdom Clinical Cytogenetics Group. Mortality in women with Turner syndrome in Great Britain: a national cohort study, J Clin Endocrinol Metab, 93, 4735, 10.1210/jc.2008-1049 Wisniewski, 2007, Weight deficit at birth and Turner's syndrome, J Pediatr Endocrinol Metab, 20, 607, 10.1515/JPEM.2007.20.5.607 Even, 2000, Longitudinal analysis of growth over the first 3years of life in Turner's syndrome, J Pediatr, 137, 460, 10.1067/mpd.2000.109110 Davenport, 2002, Growth failure in early life: an important manifestation of Turner syndrome, Horm Res, 57, 157, 10.1159/000058376 Kurtoğlu, 2010, Insulin resistance in obese children and adolescents: HOMA-IR cut-off levels in the prepubertal and pubertal periods, J Cli Res Pediatr Endocrinol, 2, 100, 10.4274/jcrpe.v2i3.100 Varvarigou, 2010, Intrauterine growth restriction as a potential risk factor for disease onset in adulthood, J Pediatr Endocrinol Metabol, 23, 215, 10.1515/JPEM.2010.23.3.215 Lee, 2003, International Small for Gestational Age Advisory Board. International Small for Gestational Age Advisory Board consensus development conference statement: management of short children born small for gestational age, April 24–October 1, 2001, Pediatrics, 111, 1253, 10.1542/peds.111.6.1253 Van Pareren, 2002, Effect of discontinuation of long-term growth hormone treatment on carbohydrate metabolism and risk factors for cardiovascular disease in girls with Turner syndrome, J Clin Endocrinol Metab, 87, 5442, 10.1210/jc.2002-020789 Bannink, 2009, Long-term follow-up of GH-treated girls with Turner syndrome: metabolic consequences, Horm Res, 71, 343, 10.1159/000223419 Gravholt, 2006, Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules, Eur J Endocrinol, 155, 583, 10.1530/eje.1.02267 Gravholt, 2002, Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study, Pediatrics, 110, 889, 10.1542/peds.110.5.889 Ekelund, 2007, Association of weight gain in infancy and early childhood with metabolic risk in young adults, J Clin Endocrinol Metab, 92, 98, 10.1210/jc.2006-1071 Pilgaard, 2010, Low birth weight and premature birth are both associated with type 2 diabetes in a random sample of middle-aged Danes, Diabetologia, 53, 2526, 10.1007/s00125-010-1917-3 Fabricius-Bjerre, 2011, Impact of birth weight and early infant weight gain on insulin resistance and associated cardiovascular risk factors in adolescence, PLoS One, 6, e-20595, 10.1371/journal.pone.0020595 Harder, 1999, Overweight and increased diabetes susceptibility in neonatally insulin-treated adult rats, Endocr Regul, 33, 25 Stoffers, 2003, Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat, Diabetes, 52, 734, 10.2337/diabetes.52.3.734 Vielwerth, 2008, The effect of birth weight upon insulin resistance and associated cardiovascular risk factors in adolescence is not explained by fetal growth velocity in the third trimester as measured by repeated ultrasound fetometry, Diabetologia, 51, 1483, 10.1007/s00125-008-1037-5 FitzSimmons, 1994, Growth parameters in mid-trimester Turner syndrome, Early Hum Dev, 38, 121, 10.1016/0378-3782(94)90223-2 Owen, 2006, Does breast feeding influence risk of type 2 diabetes in later life? A quantitative analysis of published evidence, Am J Clin Nutr, 84, 1043, 10.1093/ajcn/84.5.1043